Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Current Oncology Reports|August 3, 2021
Immune Checkpoint Inhibitors in the AgedJames Isaacs, Scott Antonia, Jeffrey ClarkeDrugs|May 21, 2022
Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung CancerJames Isaacs, Thomas E StinchcombeExpert Opinion on Investigational Drugs|April 1, 2003
Novel therapies for renal cell carcinoma--an updateMayer Fishman, Scott AntoniaClinics in Chest Medicine|May 14, 2020
Breaking the Impasse: Advances in Treatment of Small Cell Lung CancerAndreas Saltos, Scott AntoniaPlos One|February 20, 2014
PD-L1 expression is increased in a subset of basal type breast cancer cellsHatem Soliman, Farah Khalil, Scott AntoniaCurrent Treatment Options in Oncology|March 20, 2021
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast CancerJames Isaacs, Carey Anders, Heather McArthur, et al.Cancer Immunology, Immunotherapy : CII|May 20, 2008
Combined modality immunotherapy and chemotherapy: a new perspectiveRupal Ramakrishnan, Scott Antonia, Dmitry I GabrilovichCancer Chemotherapy and Pharmacology|August 22, 2009
Hepatic portal venous gas in a patient with metastatic non-small cell lung cancer on bevacizumab therapy: a case report and review of the literatureJose Ortega, J Michael Hayes, Scott AntoniaCancer Journal (Sudbury, Mass.)|August 10, 2010
Indoleamine 2,3-dioxygenase: is it an immune suppressor?Hatem Soliman, Melanie Mediavilla-Varela, Scott AntoniaCancer Management and Research|May 16, 2018
Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancerMichael R Shafique, Lary A Robinson, Scott AntoniaPageof 10